|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/282 | (2006.01) |
| A61K 31/496 | (2013.01) | ||
| A61K 31/496 | (2006.01) | ||
| A61K 31/555 | (2013.01) | ||
| A61K 31/555 | (2006.01) | ||
| A61K 31/282 | (2013.01) | ||
| A61K 33/243 | (2019.01) | ||
| A61K 33/243 | (2019.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 45/06 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/00 | (2018.01) |
| (11) | Number of the document | 4225297 |
| (13) | Kind of document | T |
| (96) | European patent application number | 21794474.3 |
| Date of filing the European patent application | 2021-10-07 | |
| (97) | Date of publication of the European application | 2023-08-16 |
| (45) | Date of publication and mention of the grant of the patent | 2024-10-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2021/077703 |
| Date | 2021-10-07 |
| (87) | Number | WO 2022/074124 |
| Date | 2022-04-14 |
| (30) | Number | Date | Country code |
| 202063089195 P | 2020-10-08 | US |
| (72) |
LEO, Elisabetta , GB
|
| (73) |
Astrazeneca AB ,
151 85 Södertälje,
SE
|
| (54) | COMBINATION THERAPY FOR TREATING CANCER |
| COMBINATION THERAPY FOR TREATING CANCER |